Clinical Data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data BioSpaceModerna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.Clinical DataRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) BioSpace Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer. Clinical DataRead full story Post navigation Previous: MSD, Eisai report setback in first-line kidney cancer trialNext: Novo Nordisk preps filings for sickle cell drug etavopivat Related Stories Clinical Data BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival pharminent May 12, 2026 Clinical Data Novo says high-dose Wegovy can cause 28% weight loss pharminent May 12, 2026 Clinical Data Pulsesight reports positive phase 1 data for PST611 in dry AMD pharminent May 11, 2026
